178 related articles for article (PubMed ID: 16134946)
21. Synthesis and antiviral activity of 2'-deoxy-4'-thio purine nucleosides.
Van Draanen NA; Freeman GA; Short SA; Harvey R; Jansen R; Szczech G; Koszalka GW
J Med Chem; 1996 Jan; 39(2):538-42. PubMed ID: 8558524
[TBL] [Abstract][Full Text] [Related]
22. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and anti-herpes virus activity of 2'-deoxy-4'-thiopyrimidine nucleosides.
Rahim SG; Trivedi N; Bogunovic-Batchelor MV; Hardy GW; Mills G; Selway JW; Snowden W; Littler E; Coe PL; Basnak I; Whale RF; Walker RT
J Med Chem; 1996 Feb; 39(3):789-95. PubMed ID: 8576922
[TBL] [Abstract][Full Text] [Related]
24. A proposed mechanism for the selective inhibition of human cytomegalovirus replication by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-fluorouracil.
Suzuki S; Misra HK; Wiebe LI; Knaus EE; Tyrrell DL
Mol Pharmacol; 1987 Mar; 31(3):301-6. PubMed ID: 3031445
[TBL] [Abstract][Full Text] [Related]
25. Effects of human alpha, beta and gamma interferons on varicella zoster virus in vitro.
Balachandra K; Thawaranantha D; Ayuthaya PI; Bhumisawasdi J; Shiraki K; Yamanishi K
Southeast Asian J Trop Med Public Health; 1994 Jun; 25(2):252-7. PubMed ID: 7855636
[TBL] [Abstract][Full Text] [Related]
26. Antiherpetic activities of N-alpha-acetyl-nona-D-arginine amide acetate.
Sumner-Smith M; Zheng Y; Zhang YP; Twist EM; Climie SC
Drugs Exp Clin Res; 1995; 21(1):1-6. PubMed ID: 7796707
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of LAVR-289, a new [(Z)-3-(acetoxymethyl)-4-(2,4-diaminopyrimidin-6-yl)oxy-but-2-enyl]phosphonic acid prodrug with pronounced antiviral activity against DNA viruses.
Bessières M; Roy V; Abuduani T; Favetta P; Snoeck R; Andrei G; Moffat J; Gallardo F; Agrofoglio LA
Eur J Med Chem; 2024 May; 271():116412. PubMed ID: 38643669
[TBL] [Abstract][Full Text] [Related]
28. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
[TBL] [Abstract][Full Text] [Related]
29. H84T BanLec has broad spectrum antiviral activity against human herpesviruses in cells, skin, and mice.
Lloyd MG; Liu D; Legendre M; Markovitz DM; Moffat JF
Sci Rep; 2022 Jan; 12(1):1641. PubMed ID: 35102178
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compounds.
Slusarchyk WA; Bisacchi GS; Field AK; Hockstein DR; Jacobs GA; McGeever-Rubin B; Tino JA; Tuomari AV; Yamanaka GA; Young MG
J Med Chem; 1992 May; 35(10):1799-806. PubMed ID: 1316966
[TBL] [Abstract][Full Text] [Related]
31. [Mechanisms of antiherpes drugs and drug resistant virus--effect of BVDU on varicella zoster virus replication].
Shigeta S; Yokota T
Rinsho Byori; 1985 Feb; 33(2):148-57. PubMed ID: 2987573
[No Abstract] [Full Text] [Related]
32. Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine.
Shiraki K; Ogino T; Yamamoto T; Yamanishi K; Takahashi M
Biken J; 1986 Mar; 29(1):11-7. PubMed ID: 3022709
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiviral evaluation of pyrazinones substituted with acyclic chains.
Davis J; Benhaddou R; Granet R; Krausz P; Demonte M; Aubertin AM
Nucleosides Nucleotides; 1998 May; 17(5):875-93. PubMed ID: 9708329
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antiviral activity of novel isonucleoside analogs.
Tino JA; Clark JM; Field AK; Jacobs GA; Lis KA; Michalik TL; McGeever-Rubin B; Slusarchyk WA; Spergel SH; Sundeen JE
J Med Chem; 1993 Apr; 36(9):1221-9. PubMed ID: 8387600
[TBL] [Abstract][Full Text] [Related]
35. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus.
Biron KK; Fyfe JA; Noblin JE; Elion GB
Am J Med; 1982 Jul; 73(1A):383-6. PubMed ID: 6285728
[TBL] [Abstract][Full Text] [Related]
36. High level expression of DNA polymerases from herpesviruses.
Ertl PF; Thomas MS; Powell KL
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1729-34. PubMed ID: 1649906
[TBL] [Abstract][Full Text] [Related]
37. Carbocyclic oxetanocins lacking the C-3' methylene.
Wu J; Schneller SW; Seley KL
J Med Chem; 1997 Apr; 40(9):1401-6. PubMed ID: 9135038
[TBL] [Abstract][Full Text] [Related]
38. [Drugs active against herpesviruses].
Fillet AM
Rev Prat; 1997 Mar; 47(6):623-30. PubMed ID: 9183936
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
Gephart JF; Lerner AM
Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
[TBL] [Abstract][Full Text] [Related]
40. [Inhibitory analysis of DNA polymerases from human viruses using modified substrates].
Kukhanova MK; Kuznetsova EV; Kraevskiĭ AA; O'Hara B; Bekker J; Morin J; Gluzman Ia
Mol Biol (Mosk); 1994; 28(3):530-41. PubMed ID: 8052245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
